Comparison of the protective effects of selective endothelin-a receptor antagonist, ambrisentan, and dual endothelin-A/B receptor antagonist, bosentan, in experimental renal ischemia reperfusion injury
2012 ◽
Vol 237
(8)
◽
pp. 894-902
◽
2002 ◽
Vol 34
(6)
◽
pp. 2387-2388
◽
2020 ◽
Vol 52
(1)
◽
pp. 392-397
◽
2016 ◽
Vol 38
(1)
◽
pp. 210-216
◽